Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial
Titel:
Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial
Auteur:
Capeding, Maria Rosario Alberto, Edison Feser, Jodi Mooney, Jessica Tang, Yuxiao Audet, Susette A. Beeler, Judy A. Ellison, Damon W. Zhang, Lei Letson, G. William Neuzil, Kathleen M. Marfin, Anthony A.